http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1097927-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_195755e705095b49c6038d68e9492cf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_259b52d5bb431a4a96959ce51adecda7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b29cd9b9d465292cb24b8df43075896
publicationDate 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1097927-A4
titleOfInvention CYANOIMINOQUINOXALINE DERIVATIVES
abstract A cyanoiminoquinoxaline derivative of the formula (II) is useful as a preventive or therapeutic agent for diseases due to hyperexcitation of glutamate receptors. <CHEM> (wherein, X and Y each is independently O or NCN, provided that at least one of X and Y is NCN; R<1>, R<2>, R<3>, and R<4> each is independently hydrogen, halogen, nitro, optionally substituted heterocyclic group etc.; R<5> is hydrogen etc.; R<1> and R<2>, R<2> and R<3>, R<3> and R<4>, and R<4> and R<5>, each taken together with the adjacent atoms may form a carbocycle which may be substituted or may contain a heteroatom(s).)
priorityDate 1998-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9719934-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231517827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18629186

Total number of triples: 31.